Clinical trial
Curcumin for the Prevention of Colon Cancer
NCT00027495 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00027495 |
|---|---|
| Title | Curcumin for the Prevention of Colon Cancer |
| Official title | Phase I Pharmacokinetic Trial of Curcuminoids Administered in a Capsule Formulation |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Dietary Supplement |
| Interventions | curcumin |
| Start date | Dec 1, 2001 |
| Primary completion | Feb 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 21, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: